Skip to main content

News

Joe Schmidt makes a surprise appearance at book launch

Last Updated:

Ireland Rugby Coach Joe Schmidt made a surprise appearance along with his wife Kelly at the book launch of 'Beautiful Thoughts For Beautiful Minds' in St Patrick’s Cathedral yesterday evening. Also in attendance was Epilepsy Ireland Patron, Rick O’Shea.

FutureNeuro partners with Ergo to develop eHealth technology

Last Updated:

FutureNeuro, the SFI Research Centre for chronic and rare neurological conditions based at RCSI, has announced its partnership with Irish Cloud solution provider Ergo to enhance crucial eHealth infrastructure in Ireland and provide improved monitoring for people living with epilepsy.

Epilepsy in Irish psychiatric inpatient settings

Last Updated:

A study published in the Irish Medical Journal has found that the prevalence of epilepsy in seven psychiatric inpatient units in Ireland was three times that of general population estimates. The prevalence of epilepsy in the general population is approximately 1% but the study has found that nine of a total of 267 patients (3.4%) in the participating psychiatric inpatient units had a diagnosis of epilepsy.

Valproate warning letters sent out

Last Updated:

The recently established Valproate Response project team have written to all female patients currently taking valproate (Epilim) outlining the risks of the drug in pregnancy and the need to discuss treatment with their medical team. These letters have been sent to 3,500 patients and are due to arrive in the post today or tomorrow.

Senator urges sodium valproate inquiry

Last Updated:

A senator is calling for an independent inquiry into sodium valproate (Epilim) – an epilepsy drug linked to birth defects. Rose Conway-Walsh, (Sinn Fein), told The Times Ireland Edition that a "do-nothing" approach was not acceptable.

Gerry Tobin: RIP

Last Updated:

Epilepsy Ireland is saddened to announce the death of Gerry Tobin while taking part in the Annual Tour De Gaggs cycle, an annual fundraiser on behalf of Epilepsy Ireland.

Epilepsy Ireland welcomes American decision to licence Epidiolex

Last Updated:

Yesterday's decision by the US Food and Drug Administration (FDA) to approve Epidiolex for the treatment of two rare and severe forms of epilepsy is a landmark moment not just for people with epilepsy in the US, but in Ireland and around the world as well.

Epidiolex is a liquid formulation of purified, plant-derived cannabidiol (CBD), a non-psychoactive component of the cannabis plant.